INVINC Polygenic Risk Score for Prostate Cancer*
฿9,812.00
Analyzes multiple inherited genetic variants and combines their effects into a polygenic risk score that estimates genetic susceptibility to prostate cancer.
Typical Use
Used to assess inherited genetic risk of developing prostate cancer and support individualised risk stratification alongside age, family history and other clinical factors. It does not diagnose prostate cancer or determine whether a person will develop the disease.
Preparation
Related tests
Alpha-1-Antitrypsin (Serum) [Rama]*
APOE Genotype for Alzheimer's Disease (Alleles E2, E3 and E4) [BML]*
APOE Genotype for Alzheimer's Disease (Alleles E2, E3 and E4) [BML] (Stat)*
APOE Genotype for Cardiovascular Diseases (Alleles E2, E3 and E4) [BML]*
Caffeine Sensitivity by CYP1A2*1F Genotyping*
Chromosome Analysis in Blood [N Health]*